The U.S. Health Resources and Service Administration (HRSA) early this month invited community health centers to “resubmit a new” 340B administrative dispute resolution (ADR) petition against drug companies that deny or restrict 340B drug discounts when contract pharmacies are involved, health centers and the government told a federal district court on Tuesday. The National Association of Community Health Centers (NACHC) told the court it intends to resubmit 340B ADR petitions “within the next week.” The action is being driven by a different federal court’s order in March putting the ADR process on hold with respect to just one company—Eli Lilly.
Health Centers Plan to Resubmit 340B Dispute Resolution Petitions
